Response to letter regarding the article “Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents”

• Published in: The American heart journal 2010-09, Vol.160 (3), p.e27-e27
• Main Authors: Rha, Seung-Woon, MD, PhD, FACC, FAHA, FESC, ESCAI, FAPSIC, Li, Yong-Jian, MD, Chen, Kang-Yin, MD, Poddar, Kanhaiya L., MD, Jin, Zhe, MD, Minami, Yoshiyasu, MD, Wang, Lin, MD, Dang, Qun, MD, Li, Guang-Ping, MD, Ramasamy, Sureshkumar, MD, Park, Ji-Young, MD, Choi, Cheol Ung, MD, Kim, Jin-Won, MD, Kim, Eung Ju, MD, Park, Chang Gyu, MD, Seo, Hong Seog, MD, Oh, Dong Joo, MD, Jeong, Myung Ho, MD, Ahn, Young Keun, MD, Hong, Taek Jong, MD, Park, Jong-Seon, MD, Kim, Young Jo, MD, Hur, Seung Ho, MD, Seong, In Whan, MD, Chae, Jei Keon, MD, Cho, Myeong Chan, MD, Bae, Jang Ho, MD, Choi, Dong Hoon, MD, Jang, Yang Soo, MD, Chae, In Ho, MD, Kim, Hyo Soo, MD, Kim, Chong Jin, MD, Yoon, Jung Han, MD, Ahn, Tae Hoon, MD, Tahk, Seung-Jea, MD, Chung, Wook Sung, MD, Seung, Ki Bae, MD, Park, Seung Jung, MD
• Format: Article
• Language: English
• Subjects: Cardiovascular; Clinical outcomes; Drug therapy; Heart attacks
• ISSN: 0002-8703; 1097-6744
• DOI: 10.1016/j.ahj.2010.06.037

Because of the nature of registry study, some patients received UFH for >2 days because some physicians thought the prolonged antithrombotic therapy might give extra benefits to the patients with higher risk of thrombotic complications.